Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Return on Assets (2019 - 2025)

Historic Return on Assets for Exagen (XGN) over the last 7 years, with Q3 2025 value amounting to 0.31%.

  • Exagen's Return on Assets rose 500.0% to 0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.3% for FY2024, which is 300.0% up from last year.
  • Latest data reveals that Exagen reported Return on Assets of 0.31% as of Q3 2025, which was up 500.0% from 0.34% recorded in Q2 2025.
  • Exagen's Return on Assets' 5-year high stood at 0.15% during Q2 2021, with a 5-year trough of 0.55% in Q1 2023.
  • For the 5-year period, Exagen's Return on Assets averaged around 0.35%, with its median value being 0.35% (2024).
  • Its Return on Assets has fluctuated over the past 5 years, first crashed by -3000bps in 2022, then soared by 2000bps in 2024.
  • Over the past 5 years, Exagen's Return on Assets (Quarter) stood at 0.21% in 2021, then plummeted by -142bps to 0.52% in 2022, then increased by 22bps to 0.4% in 2023, then rose by 15bps to 0.34% in 2024, then grew by 9bps to 0.31% in 2025.
  • Its Return on Assets was 0.31% in Q3 2025, compared to 0.34% in Q2 2025 and 0.36% in Q1 2025.